COO 📈 The Cooper Companies - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2166484020
COO: Contact Lenses, Fertility Products, Medical Devices, Contraceptives
The Cooper Companies, Inc. is a multinational medical device company that specializes in the development, manufacture, and marketing of products for contact lens wearers and healthcare professionals. Through its two primary segments, CooperVision and CooperSurgical, the company offers a diverse range of products that cater to various needs in the healthcare industry. CooperVision, for instance, provides a wide array of spherical lenses, including those that correct near and farsightedness, as well as toric and multifocal lenses that address vision challenges such as astigmatism, presbyopia, and myopia. These products are distributed across the Americas, Europe, Middle East, Africa, and Asia Pacific, making CooperVision a significant player in the global contact lens market.
The CooperSurgical segment, on the other hand, focuses on family and women's healthcare, providing a broad range of fertility products and services, medical devices, and contraception solutions to healthcare professionals and patients worldwide. This includes surgical and office products like endosee endometrial imaging products, fetal pillow cephalic elevation devices, and illuminated speculum products, among others. Additionally, the company offers cryostorage services, such as cord blood and cord tissue storage, as well as fertility products and services like fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. By catering to the diverse needs of healthcare professionals and patients, CooperSurgical has established itself as a trusted provider of women's healthcare solutions.
In terms of its sales strategy, The Cooper Companies, Inc. sells its products to a wide range of customers, including distributors, group purchasing organizations, eye care and healthcare professionals, independent practices, corporate retailers, hospitals, clinics, and authorized resellers. This multi-channel approach enables the company to reach a broad audience and expand its market presence. With a history dating back to 1958, The Cooper Companies, Inc. has evolved into a leading player in the healthcare industry, with its headquarters located in San Ramon, California. The company's website, https://www.coopercos.com, provides more information about its products, services, and mission. As a publicly traded company, The Cooper Companies, Inc.'s common stock is listed on the NASDAQ stock exchange under the ticker symbol COO, with the ISIN code US2166484020, and is classified under the GICS Sub Industry of Health Care Supplies.
Additional Sources for COO Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
COO Stock Overview
Market Cap in USD | 19,811m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 1983-12-30 |
COO Stock Ratings
Growth 5y | 20.4% |
Fundamental | 25.8% |
Dividend | 7.22% |
Rel. Strength Industry | -133 |
Analysts | 4/5 |
Fair Price Momentum | 78.12 USD |
Fair Price DCF | 24.58 USD |
COO Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 65.7% |
COO Growth Ratios
Growth Correlation 3m | -91.8% |
Growth Correlation 12m | 36.3% |
Growth Correlation 5y | 27.9% |
CAGR 5y | 3.06% |
CAGR/Mean DD 5y | 0.20 |
Sharpe Ratio 12m | -0.15 |
Alpha | -30.16 |
Beta | 1.00 |
Volatility | 28.72% |
Current Volume | 451.2k |
Average Volume 20d | 1681.1k |
As of December 26, 2024, the stock is trading at USD 92.81 with a total of 451,163 shares traded.
Over the past week, the price has changed by +0.45%, over one month by -9.37%, over three months by -14.39% and over the past year by -1.52%.
Neither. Based on ValueRay Fundamental Analyses, The Cooper Companies is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.79 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COO as of December 2024 is 78.12. This means that COO is currently overvalued and has a potential downside of -15.83%.
The Cooper Companies has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy COO.
- Strong Buy: 9
- Buy: 2
- Hold: 7
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, COO The Cooper Companies will be worth about 86.2 in December 2025. The stock is currently trading at 92.81. This means that the stock has a potential downside of -7.11%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 112.3 | 21% |
Analysts Target Price | 400.2 | 331.2% |
ValueRay Target Price | 86.2 | -7.1% |